Search - tctmd.com

Displaying 1 - 20 of 35

Sort: Relevancy | Date

News Conference News ESC 2025

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

Michael O'Riordan

September 10, 2025

News

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

Michael O'Riordan

May 30, 2024

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

Query Use of Nontraditional Therapies for HF at Every Visit: AHA Statement

Todd Neale

December 09, 2022

News Daily News

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

Michael O'Riordan

December 07, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2022

Shelley Wood

October 31, 2022

News Daily News

Early Data Suggest Plant-Based Foods Could Improve Outcomes in HF

L.A. McKeown

October 26, 2022

News Daily News

VITAL Rhythm Data May Flip the Script on AF Screening in Women

L.A. McKeown

September 08, 2022

News Daily News

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Caitlin E. Cox

July 08, 2022

News Daily News

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Yael L. Maxwell

June 23, 2022

News Daily News

Omega-3 Fatty Acids Linked to BP Reductions, Meta-analysis Hints

L.A. McKeown

June 06, 2022

News Daily News

Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S

Caitlin E. Cox

January 07, 2022

News Conference News AHA 2021

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

Todd Neale

November 15, 2021

News Opinion CV Team Dispatch

May 2021 News Roundup

L.A. McKeown

May 01, 2021

News Daily News

Biggest Benefits of Regular Fish Consumption Lie in Secondary Prevention

Michael O'Riordan

March 11, 2021

News Opinion CV Team Dispatch

February 2021 News Roundup

L.A. McKeown

February 01, 2021

News Conference News AHA 2020

OMEMI: Omega-3 Fatty Acids No Help in Elderly MI Patients

Todd Neale

November 15, 2020

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

News Daily News

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Michael O'Riordan

November 14, 2019

Advertisement

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Query Use of Nontraditional Therapies for HF at Every Visit: AHA Statement

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

TCTMD’s Top 10 Most Popular Stories for October 2022

Early Data Suggest Plant-Based Foods Could Improve Outcomes in HF

VITAL Rhythm Data May Flip the Script on AF Screening in Women

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Omega-3 Fatty Acids Linked to BP Reductions, Meta-analysis Hints

Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

May 2021 News Roundup

Biggest Benefits of Regular Fish Consumption Lie in Secondary Prevention

February 2021 News Roundup

OMEMI: Omega-3 Fatty Acids No Help in Elderly MI Patients

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content